Hsbc Holdings PLC boosted its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 45.0% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 403,283 shares of the real estate investment trust's stock after purchasing an additional 125,211 shares during the period. Hsbc Holdings PLC owned 0.17% of Sabra Healthcare REIT worth $7,058,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. State of Michigan Retirement System grew its holdings in Sabra Healthcare REIT by 1.1% during the first quarter. State of Michigan Retirement System now owns 56,649 shares of the real estate investment trust's stock valued at $990,000 after purchasing an additional 600 shares during the period. Louisiana State Employees Retirement System boosted its holdings in shares of Sabra Healthcare REIT by 0.9% in the first quarter. Louisiana State Employees Retirement System now owns 66,300 shares of the real estate investment trust's stock worth $1,158,000 after acquiring an additional 600 shares during the period. Harbor Capital Advisors Inc. boosted its stake in Sabra Healthcare REIT by 17.2% during the first quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock valued at $76,000 after buying an additional 642 shares during the period. Diversify Advisory Services LLC boosted its stake in Sabra Healthcare REIT by 5.7% during the first quarter. Diversify Advisory Services LLC now owns 12,878 shares of the real estate investment trust's stock valued at $226,000 after buying an additional 689 shares during the period. Finally, IFP Advisors Inc boosted its stake in Sabra Healthcare REIT by 16.2% during the first quarter. IFP Advisors Inc now owns 5,060 shares of the real estate investment trust's stock valued at $88,000 after buying an additional 706 shares during the period. Institutional investors and hedge funds own 99.40% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on the company. Wells Fargo & Company raised their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research report on Wednesday. JMP Securities raised their price target on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research report on Wednesday, August 6th. Scotiabank raised their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. Finally, BMO Capital Markets raised their price target on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research report on Monday. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $20.43.
Get Our Latest Analysis on SBRA
Sabra Healthcare REIT Trading Down 1.0%
Shares of SBRA traded down $0.20 during trading hours on Friday, hitting $19.11. The company had a trading volume of 2,586,825 shares, compared to its average volume of 2,461,291. The firm has a market cap of $4.58 billion, a P/E ratio of 25.15, a P/E/G ratio of 1.56 and a beta of 0.86. The stock's 50 day moving average price is $18.54 and its 200 day moving average price is $17.76. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $20.03.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping the consensus estimate of $0.36 by $0.02. The firm had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The company's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.
Sabra Healthcare REIT Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Friday, August 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.3%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT's payout ratio is currently 157.89%.
Sabra Healthcare REIT Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Stories

Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.